Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)
Clinical trial NCT02234960 · COMPLETED
Trial details
- NCT number
- NCT02234960
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-07-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.